Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioMarin Pharmaceutical Inc.
  6. News
  7. Summary
    BMRN   US09061G1013

BIOMARIN PHARMACEUTICAL INC.

(BMRN)
  Report
Real-time Estimate Cboe BZX  -  12:19 2022-08-16 pm EDT
95.82 USD   -1.16%
08/12INSIDER SELL : Biomarin Pharmaceutical
MT
08/09Piper Sandler Adjusts Price Target on BioMarin Pharmaceutical to $128 From $125, Reiterates Overweight Rating
MT
08/04BIOMARIN PHARMACEUTICAL INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Outpacing Broader Markets, Other Sectors to Upside

06/22/2022 | 01:42pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ATHIRA PHARMA, INC. 1.67% 3.965 Delayed Quote.-70.07%
BIOMARIN PHARMACEUTICAL INC. -1.16% 95.77 Delayed Quote.9.72%
ENANTA PHARMACEUTICALS, INC. -1.68% 69.275 Delayed Quote.-5.78%
EURO / BRAZILIAN REAL (EUR/BRL) 1.04% 5.2332 Delayed Quote.-17.97%
NASDAQ COMPOSITE -0.02% 13125 Real-time Quote.-16.09%
PFIZER, INC. -0.15% 49.645 Delayed Quote.-15.75%
All news about BIOMARIN PHARMACEUTICAL INC.
08/12INSIDER SELL : Biomarin Pharmaceutical
MT
08/09Piper Sandler Adjusts Price Target on BioMarin Pharmaceutical to $128 From $125, Reiter..
MT
08/04BIOMARIN PHARMACEUTICAL INC Management's Discussion and Analysis of Financial Conditio..
AQ
08/04Morgan Stanley Adjusts BioMarin Pharmaceutical's Price Target to $117 from $113, Keeps ..
MT
08/04Credit Suisse Raises BioMarin Pharmaceutical's Price Target to $111 from $107 After Hig..
MT
08/04SVB Securities Raises BioMarin Pharmaceutical's Price Target to $122 From $115, Reitera..
MT
08/04Goldman Sachs Trims BioMarin Pharmaceutical's Price Target to $174 From $176, Maintains..
MT
08/04Oppenheimer Adjusts BioMarin Pharmaceutical's Price Target to $92 From $94, Maintains P..
MT
08/04Barclays Adjusts BioMarin Pharmaceutical's Price Target to $125 From $112, Keeps Overwe..
MT
08/03BIOMARIN PHARMACEUTICAL : Announces Record Revenues in Second Quarter 2022; Increases Full..
PU
More news
Analyst Recommendations on BIOMARIN PHARMACEUTICAL INC.
More recommendations
Financials (USD)
Sales 2022 2 122 M - -
Net income 2022 146 M - -
Net cash 2022 459 M - -
P/E ratio 2022 129x
Yield 2022 -
Capitalization 17 933 M 17 933 M -
EV / Sales 2022 8,24x
EV / Sales 2023 6,44x
Nbr of Employees 3 045
Free-Float 99,4%
Chart BIOMARIN PHARMACEUTICAL INC.
Duration : Period :
BioMarin Pharmaceutical Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOMARIN PHARMACEUTICAL INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Last Close Price 96,94 $
Average target price 114,14 $
Spread / Average Target 17,7%
EPS Revisions
Managers and Directors
Jean-Jacques Bienaimé Chairman & Chief Executive Officer
Brian R. Mueller Chief Financial Officer & Executive VP-Finance
Henry J. Fuchs President-Worldwide Research & Development
Eduardo E. von Pervieux Chief Information Officer
C. Greg Guyer Chief Technical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
BIOMARIN PHARMACEUTICAL INC.9.72%17 933
CSL LIMITED0.87%99 406
SAMSUNG BIOLOGICS CO.,LTD.0.78%49 423
WUXI BIOLOGICS (CAYMAN) INC.-24.04%38 248
BIOGEN INC.-7.31%32 270
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-22.05%22 943